Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.
暂无分享,去创建一个
A. Colombo | G. Sardella | G. Tarantini | G. Giustino | A. Chieffo | R. Garbo | A. Frasheri | Mónica Masotti-Centol | N. Salvatella | L. Steffanon | P. Presbitero | A. Menozzi | E. Pucci | J. Mauri | C. Fraccaro | L. Nai Fovino | P. Tellaroli | Alberto Barioli | J. F. O. Dominguez